KORU Medical Systems, Inc. has signed an amendment to its manufacturing and supply agreement with Command Medical Products. The changes extend the contract's initial term to December 2031, adjust pricing and payment terms, and require Command to qualify a second manufacturing site by December 31, 2027. If Command fails to meet that deadline, KORU can terminate the agreement after a 30-day cure period. The amendment also clarifies intellectual property ownership, broadens wind-up period rights, and removes a non-competition clause.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding KORU MEDICAL SYSTEMS INC (KRMD)?

Major stakeholders currently include First Light Asset Management, LLC ($16.3M), Topline Capital Management, LLC ($15.2M), BlackRock, Inc. ($10.2M). Based on the latest 13F filings, there are a total of 91 tracked investment funds and institutions maintaining positions in KRMD.

What is the overall institutional sentiment toward KRMD recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $31.5M, driven by 43 managers accumulating shares while 37 reduced their exposure.

Which institutions have been selling or reducing their KRMD positions?

In the latest period, 26 funds trimmed their holdings, and 11 managers completely exited their positions. The aggregate reported sell value was $76.0M.

Are there any notable investors adding KRMD to their portfolios?

Yes, buying activity remains notable. 15 institutions opened new positions in {ticker}, and 28 existing holders added to their shares. The total reported buy value for the quarter amounted to $24.4M.